EBACU
Income statement / Annual
Last year (2022), European Biotech Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, European Biotech Acquisition Corp.'s net income was $3.50 M.
See European Biotech Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
| General & Administrative Expenses |
$2.79 M
|
$1.10 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.79 M
|
$1.10 M
|
| Other Expenses |
$32,943.00
|
$0.00
|
| Operating Expenses |
$2.82 M
|
$1.10 M
|
| Cost And Expenses |
$2.82 M
|
$1.10 M
|
| Interest Income |
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
| Depreciation & Amortization |
-$3.16 M
|
-$2.58 M
|
| EBITDA |
-$2.82 M |
-$3.68 M |
| EBITDA Ratio |
0
|
0
|
| Operating Income Ratio |
0
|
0
|
| Total Other Income/Expenses Net |
$3.16 M
|
$2.58 M
|
| Income Before Tax |
$342,895.00
|
$1.48 M
|
| Income Before Tax Ratio |
0
|
0
|
| Income Tax Expense |
-$3.16 M
|
$0.00
|
| Net Income |
$3.50 M
|
$1.48 M
|
| Net Income Ratio |
0
|
0
|
| EPS |
0.27 |
0.43 |
| EPS Diluted |
0.27 |
0.11 |
| Weighted Average Shares Out |
$12.75 M
|
$13.66 M
|
| Weighted Average Shares Out Diluted |
$12.75 M
|
$13.66 M
|
| Link |
|
|
